Predilife announces the great success of its capital increase to finance its growth.
« I would like to thank all the subscribers for their interest in this project and the confidence they have shown in us. The success of this capital increase provides us with increased financial resources to accelerate the commercial deployment of the Mammorisk® solution in Europe. »
Stéphane Ragusa – Chairman and CEO
Access to the press release announcing the success of the capital increase.